Matthew Hsieh, MD

Matthew Hsieh is an active investigator in several intramural and extramural clinical trials for sickle cell disease, including hematopoietic cell transplantation (HCT) from matched related and haploidentical donors, industry sponsored clinical trials for gene therapy, and late effects of HCT. He is on the faculty for the combined NHLBI/NCI hematology and oncology fellowship program. His expertise and research interests include stem cell mobilization, organ dysfunction related sickle and beta-globin disorders, iron overload, neutrophil disorders, and HCT conditioning regimens.

Publications

Two non-myeloablative HLA-matched related donor allogeneic hematopoietic cell transplant regimens in patients with sickle cell disease

Pulmonary function after nonmyeloablative hematopoietic cell transplant for sickle cell disease

Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell disease

Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant

Analyses of genome wide association data, cytokines, and gene expression in African-Americans with benign ethnic neutropenia.

See full bibliography.